Dark Forest Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Dark Forest Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-77,849	Closed	-$327K	–	1570
2023 Q1	$327K	Buy	77,849 +77,569	+27,703%	+$403K	0.08%	244
2022 Q4	$1.68K	Sell	280 -4,621	-94%	-$25.2K	﹤0.01%	958
2022 Q3	$29K	Buy	+4,901	New	+$30.5K	﹤0.01%	581

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Dark Forest Capital Management's CTIC Position: Q2 2023 in Review

Dark Forest Capital Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 77,849 shares — an estimated $327K sold.

Dark Forest Capital Management first reported a position in CTIC in Q3 2022 and held it in 3 quarters. The position peaked at $327K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Dark Forest Capital Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Dark Forest Capital Management sold 77,849 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $327K.
Dark Forest Capital Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2022 and held it in 3 quarters.
Dark Forest Capital Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $327K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.